Hologic - News Releases http://investors.hologic.com/ Hologic Receives FDA 510(k) Clearance of Quantra™ 2.2 Breast Density Assessment Software http://investors.hologic.com/2017-11-24-Hologic-Receives-FDA-510-k-Clearance-of-Quantra-TM-2-2-Breast-Density-Assessment-Software --Latest addition to market-leading portfolio of innovative breast and skeletal health solutions to be featured at RSNA 2017-- Fri, 24 Nov 2017 08:05:00 -0500 http://investors.hologic.com/2017-11-24-Hologic-Receives-FDA-510-k-Clearance-of-Quantra-TM-2-2-Breast-Density-Assessment-Software Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2043 http://investors.hologic.com/2017-11-14-Hologic-Announces-Upcoming-Put-Option-and-Notice-of-Redemption-of-2-00-Convertible-Senior-Notes-Due-2043 Tue, 14 Nov 2017 16:01:00 -0500 http://investors.hologic.com/2017-11-14-Hologic-Announces-Upcoming-Put-Option-and-Notice-of-Redemption-of-2-00-Convertible-Senior-Notes-Due-2043 Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 http://investors.hologic.com/2017-11-08-Hologic-Announces-Financial-Results-for-Fourth-Quarter-of-Fiscal-2017 -- Company Posts Revenue of $802.9 Million, GAAP Diluted EPS of $0.29, and Non-GAAP Diluted EPS of $0.50 -- Wed, 08 Nov 2017 16:01:00 -0500 http://investors.hologic.com/2017-11-08-Hologic-Announces-Financial-Results-for-Fourth-Quarter-of-Fiscal-2017 Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2017-11-06-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Mon, 06 Nov 2017 08:10:00 -0500 http://investors.hologic.com/2017-11-06-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Hologic Launches the MyoSure® MANUAL Device to Help Doctors Remove Intrauterine Tissue In-Office http://investors.hologic.com/2017-11-01-Hologic-Launches-the-MyoSure-R-MANUAL-Device-to-Help-Doctors-Remove-Intrauterine-Tissue-In-Office Wed, 01 Nov 2017 08:07:00 -0400 http://investors.hologic.com/2017-11-01-Hologic-Launches-the-MyoSure-R-MANUAL-Device-to-Help-Doctors-Remove-Intrauterine-Tissue-In-Office Hologic and Tromp Medical to Provide All Mammography Systems for the Dutch Breast Cancer Screening Program http://investors.hologic.com/news?item=675 -- Under the tender, state-of-the-art 3Dimensions™ mammography systems will be installed starting in 2018 -- Wed, 01 Nov 2017 08:00:00 -0400 http://investors.hologic.com/news?item=675 Paraflu Assay Now FDA Cleared on Hologic's New Panther Fusion® System http://investors.hologic.com/2017-10-26-Paraflu-Assay-Now-FDA-Cleared-on-Hologics-New-Panther-Fusion-R-System -- New Assay Extends Respiratory Testing Menu; Modular Panels and Fusion System Increase Efficiency and Flexibility for the Laboratory -- Thu, 26 Oct 2017 08:07:00 -0400 http://investors.hologic.com/2017-10-26-Paraflu-Assay-Now-FDA-Cleared-on-Hologics-New-Panther-Fusion-R-System Hologic Receives CE Mark to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin) http://investors.hologic.com/2017-10-17-Hologic-Receives-CE-Mark-to-Market-SculpSure-R-for-Non-Invasive-Body-Contouring-Lipolysis-of-the-Submental-Area-Under-the-Chin Tue, 17 Oct 2017 03:00:00 -0400 http://investors.hologic.com/2017-10-17-Hologic-Receives-CE-Mark-to-Market-SculpSure-R-for-Non-Invasive-Body-Contouring-Lipolysis-of-the-Submental-Area-Under-the-Chin The common condition costing £531m a year in lost work days http://investors.hologic.com/Wear-White-Again --73% of women with heavy periods lie about the reason for taking days off, suggesting this common condition, which affects 1 in 5 women,2 is still a taboo -- Wed, 11 Oct 2017 13:21:00 -0400 http://investors.hologic.com/Wear-White-Again Panther Fusion® Flu A/B/RSV Assay Now FDA Cleared on Hologic's New Panther Fusion® System http://investors.hologic.com/2017-10-05-Panther-Fusion-R-Flu-A-B-RSV-Assay-Now-FDA-Cleared-on-Hologics-New-Panther-Fusion-R-System - New Panther Fusion Module Expands System's Molecular Testing Capabilities, Increases Efficiency and Flexibility for the Laboratory Thu, 05 Oct 2017 16:01:00 -0400 http://investors.hologic.com/2017-10-05-Panther-Fusion-R-Flu-A-B-RSV-Assay-Now-FDA-Cleared-on-Hologics-New-Panther-Fusion-R-System Hologic Announces Pricing of Offering of $350 Million Aggregate Principal Amount of 4.375% Senior Notes Due 2025 http://investors.hologic.com/2017-10-04-Hologic-Announces-Pricing-of-Offering-of-350-Million-Aggregate-Principal-Amount-of-4-375-Senior-Notes-Due-2025 Wed, 04 Oct 2017 18:01:00 -0400 http://investors.hologic.com/2017-10-04-Hologic-Announces-Pricing-of-Offering-of-350-Million-Aggregate-Principal-Amount-of-4-375-Senior-Notes-Due-2025 New Study Shows Increased Fetal Fibronectin (fFN) Testing in Pregnant Women Could Help Guide Better Patient Care http://investors.hologic.com/fFN_study -- Increased fFN testing could improve care management by preventing more women with symptoms of preterm labor from being discharged from the hospital too soon -- Wed, 04 Oct 2017 08:00:00 -0400 http://investors.hologic.com/fFN_study Hologic Announces Offering of $350 Million of Senior Notes Due 2025 http://investors.hologic.com/2017-10-04-Hologic-Announces-Offering-of-350-Million-of-Senior-Notes-Due-2025 - Proceeds Expected to Contribute to Retirement of Remaining Convertible Notes - Wed, 04 Oct 2017 07:02:00 -0400 http://investors.hologic.com/2017-10-04-Hologic-Announces-Offering-of-350-Million-of-Senior-Notes-Due-2025 Hologic Enters into Amended and Restated Five-Year Secured Credit Agreement http://investors.hologic.com/2017-10-04-Hologic-Enters-into-Amended-and-Restated-Five-Year-Secured-Credit-Agreement - Initial Proceeds from New $1.5 Billion Term Loan and $1.5 Billion Revolving Credit Line Used to Refinance Senior Secured Debt - Wed, 04 Oct 2017 07:02:00 -0400 http://investors.hologic.com/2017-10-04-Hologic-Enters-into-Amended-and-Restated-Five-Year-Secured-Credit-Agreement Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2017 on Wednesday, November 8, 2017 http://investors.hologic.com/2017-10-03-Hologic-to-Announce-Financial-Results-for-the-Fourth-Quarter-of-Fiscal-2017-on-Wednesday-November-8-2017 Tue, 03 Oct 2017 16:01:00 -0400 http://investors.hologic.com/2017-10-03-Hologic-to-Announce-Financial-Results-for-the-Fourth-Quarter-of-Fiscal-2017-on-Wednesday-November-8-2017 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 to Kick Off Breast Cancer Awareness Month http://investors.hologic.com/2017-09-29-Hologic-CEO-Steve-MacMillan-to-Ring-Nasdaq-Opening-Bell-on-October-2-to-Kick-Off-Breast-Cancer-Awareness-Month Trailblazing Company Behind the Genius™ 3D Mammography™ Exam Celebrates Year of Innovations in Breast Health Fri, 29 Sep 2017 08:07:00 -0400 http://investors.hologic.com/2017-09-29-Hologic-CEO-Steve-MacMillan-to-Ring-Nasdaq-Opening-Bell-on-October-2-to-Kick-Off-Breast-Cancer-Awareness-Month Hologic Receives FDA 510(k) Clearance to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin) http://investors.hologic.com/2017-09-27-Hologic-Receives-FDA-510-k-Clearance-to-Market-SculpSure-R-for-Non-Invasive-Body-Contouring-Lipolysis-of-the-Submental-Area-Under-the-Chin Patients in Clinical Studies Report 100% Satisfaction Rate Wed, 27 Sep 2017 08:00:00 -0400 http://investors.hologic.com/2017-09-27-Hologic-Receives-FDA-510-k-Clearance-to-Market-SculpSure-R-for-Non-Invasive-Body-Contouring-Lipolysis-of-the-Submental-Area-Under-the-Chin New USPSTF Draft Cervical Cancer Screening Recommendations Are a Step Back for Women's Health, Would Put Lives at Risk http://investors.hologic.com/2017-09-14-New-USPSTF-Draft-Cervical-Cancer-Screening-Recommendations-Are-a-Step-Back-for-Womens-Health-Would-Put-Lives-at-Risk Thu, 14 Sep 2017 08:12:00 -0400 http://investors.hologic.com/2017-09-14-New-USPSTF-Draft-Cervical-Cancer-Screening-Recommendations-Are-a-Step-Back-for-Womens-Health-Would-Put-Lives-at-Risk Hologic’s 3Dimensions™ Mammography System Now Available in Europe http://investors.hologic.com/3Dimensions --Fastest, Highest Resolution Breast Tomosynthesis System is Designed to Increase Clinical Confidence, Accuracy and Patient Comfort-- Mon, 11 Sep 2017 08:00:00 -0400 http://investors.hologic.com/3Dimensions Hologic Announces Availability of New Brevera® Breast Biopsy System with CorLumina® Imaging Technology http://investors.hologic.com/2017-08-31-Hologic-Announces-Availability-of-New-Brevera-R-Breast-Biopsy-System-with-CorLumina-R-Imaging-Technology Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings Thu, 31 Aug 2017 08:00:00 -0400 http://investors.hologic.com/2017-08-31-Hologic-Announces-Availability-of-New-Brevera-R-Breast-Biopsy-System-with-CorLumina-R-Imaging-Technology Hologic Announces Financial Results for Third Quarter of Fiscal 2017 http://investors.hologic.com/2017-08-02-Hologic-Announces-Financial-Results-for-Third-Quarter-of-Fiscal-2017 -- Company Posts Revenue of $806.1 Million, GAAP Diluted EPS of $0.21, and Non-GAAP Diluted EPS of $0.50 -- Wed, 02 Aug 2017 16:01:00 -0400 http://investors.hologic.com/2017-08-02-Hologic-Announces-Financial-Results-for-Third-Quarter-of-Fiscal-2017 Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2017-07-31-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Mon, 31 Jul 2017 16:01:00 -0400 http://investors.hologic.com/2017-07-31-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Hologic to Announce Financial Results for the Third Quarter of Fiscal 2017 on Wednesday, August 2, 2017 http://investors.hologic.com/2017-07-05-Hologic-to-Announce-Financial-Results-for-the-Third-Quarter-of-Fiscal-2017-on-Wednesday-August-2-2017 Wed, 05 Jul 2017 16:01:00 -0400 http://investors.hologic.com/2017-07-05-Hologic-to-Announce-Financial-Results-for-the-Third-Quarter-of-Fiscal-2017-on-Wednesday-August-2-2017 Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert http://investors.hologic.com/2017-07-03-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Mon, 03 Jul 2017 13:00:00 -0400 http://investors.hologic.com/2017-07-03-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Hologic's New Panther Fusion® System, Flu and Respiratory Assays Now CE Marked in Europe http://investors.hologic.com/2017-06-29-Hologics-New-Panther-Fusion-R-System-Flu-and-Respiratory-Assays-Now-CE-Marked-in-Europe -- New Panther Fusion® Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory Thu, 29 Jun 2017 08:00:00 -0400 http://investors.hologic.com/2017-06-29-Hologics-New-Panther-Fusion-R-System-Flu-and-Respiratory-Assays-Now-CE-Marked-in-Europe